| 2026-04-29 |
财报披露：
美东时间 2026-04-29 盘前发布财报
|
| 2026-03-06 |
股东大会：
将于2026-04-16召开股东大会
会议内容 ▼▲
- 1.Elect the ten director nominees named in the proxy statement.
2.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2026.
3.Non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers.
4.Approve the Humana Inc. 2026 Stock Incentive Plan.
5.Consider and vote upon the stockholder proposal set forth in this proxy statement, if properly presented at the meeting.
6.Consider any other business properly brought before the meeting.
|
| 2026-03-06 |
详情>>
股本变动：
变动后总股本12005.45万股
|
| 2026-02-24 |
详情>>
内部人交易：
Renaudin George II等共交易4笔
|
| 2026-02-19 |
详情>>
业绩披露：
2025年年报每股收益9.87美元,归母净利润11.88亿美元,同比去年增长-1.57%
|
| 2025-11-05 |
详情>>
业绩披露：
2025年三季报(累计)每股收益16.47美元,归母净利润19.84亿美元,同比去年增长4.42%
|
| 2025-07-30 |
详情>>
业绩披露：
2025年中报每股收益14.83美元,归母净利润17.89亿美元,同比去年增长25.99%
|
| 2025-04-30 |
详情>>
业绩披露：
2025年一季报每股收益10.31美元,归母净利润12.44亿美元,同比去年增长67.88%
|
| 2025-03-07 |
股东大会：
将于2025-04-17召开股东大会
会议内容 ▼▲
- 1.Elect the eleven director nominees named in the proxy statement.
2.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2025.
3.Non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers.
4.Consider any other business properly brought before the meeting.
|
| 2025-02-20 |
详情>>
业绩披露：
2024年年报每股收益10.01美元,归母净利润12.07亿美元,同比去年增长-51.51%
|
| 2025-02-20 |
详情>>
业绩披露：
2022年年报每股收益22.20美元,归母净利润28.06亿美元,同比去年增长-4.33%
|
| 2024-10-30 |
详情>>
业绩披露：
2024年三季报(累计)每股收益15.76美元,归母净利润19.00亿美元,同比去年增长-37.29%
|
| 2024-10-30 |
详情>>
业绩披露：
2023年三季报(累计)每股收益24.37美元,归母净利润30.30亿美元,同比去年增长7.41%
|
| 2024-07-31 |
详情>>
业绩披露：
2024年中报每股收益11.76美元,归母净利润14.20亿美元,同比去年增长-35.4%
|
| 2024-04-24 |
详情>>
业绩披露：
2024年一季报每股收益6.13美元,归母净利润7.41亿美元,同比去年增长-40.19%
|
| 2024-03-08 |
股东大会：
将于2024-04-18召开股东大会
会议内容 ▼▲
- 1.Elect the eleven (11) director nominees named in the proxy statement.
2.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2024.
3.Non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers.
4.Approve amendment to the Company’s Restated Certificate of Incorporation to limit the liability of certain officers of the Company as permitted by Delaware law.
5.Approve amendment to the Company’s Restated Certificate of Incorporation to eliminate supermajority voting requirement in connection with certain transactions.
6.Consider and vote upon the stockholder proposal set forth in this proxy statement, if properly presented at the meeting.
7.Consider any other business properly brought before the meeting.
|
| 2024-02-15 |
详情>>
业绩披露：
2023年年报每股收益20.09美元,归母净利润24.89亿美元,同比去年增长-11.3%
|
| 2023-03-08 |
股东大会：
将于2023-04-20召开股东大会
会议内容 ▼▲
- 1.Elect the twelve (12) director nominees named in the proxy statement.
2.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2023.
3.Non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers.
4.Non-binding advisory vote regarding the frequency of the voting with respect to the compensation of the Company’s Named Executive Officers.
5.Consider any other business properly brought before the meeting.
|
| 2022-03-09 |
股东大会：
将于2022-04-21召开股东大会
会议内容 ▼▲
- 1.Elect the thirteen (13) director nominees named in the proxy statement.
2.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2022.
3.Non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers.
4.Consider any other business properly brought before the meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-10 |
股东大会：
将于2021-04-22召开股东大会
会议内容 ▼▲
- 1.Elect the thirteen (13) director nominees named in the proxy statement.
2.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2021.
3.Non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers.
4.Consider any other business properly brought before the meeting.
|
| 2020-04-23 |
除权日：
美东时间 2020-06-29 每股派息0.63美元
|
| 2020-03-04 |
股东大会：
将于2020-04-23召开股东大会
会议内容 ▼▲
- 1.Elect the twelve (12) director nominees named in the proxy statement.
2.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2020.
3.Non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers.
4.Consider any other business properly brought before the meeting.
|
| 2020-02-20 |
除权日：
美东时间 2020-03-30 每股派息0.63美元
|
| 2019-10-24 |
除权日：
美东时间 2019-12-30 每股派息0.55美元
|
| 2019-08-22 |
除权日：
美东时间 2019-09-27 每股派息0.55美元
|
| 2019-04-18 |
除权日：
美东时间 2019-06-27 每股派息0.55美元
|
| 2019-03-06 |
股东大会：
将于2019-04-18召开股东大会
会议内容 ▼▲
- 1.Elect the ten (10) director nominees named in the proxy statement.
2.Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2019.
3.Non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers.
4.Approve the Amended and Restated Humana Inc. Stock Incentive Plan.
5.Consider any other business properly brought before the meeting.
|
| 2018-04-19 |
除权日：
美东时间 2018-06-28 每股派息0.50美元
|
| 2018-03-07 |
股东大会：
将于2018-04-19召开股东大会
会议内容 ▼▲
- 1. Elect the twelve (12) director nominees named in the proxy statement.
2. Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2018.
3. Non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers.
4. Consider any other business properly brought before the meeting.
|
| 2018-02-06 |
除权日：
美东时间 2018-03-28 每股派息0.50美元
|
| 2017-11-02 |
除权日：
美东时间 2017-12-28 每股派息0.40美元
|
| 2017-08-17 |
除权日：
美东时间 2017-09-28 每股派息0.40美元
|
| 2017-04-20 |
除权日：
美东时间 2017-06-28 每股派息0.40美元
|
| 2017-03-08 |
股东大会：
将于2017-04-20召开股东大会
会议内容 ▼▲
- 1. Elect the ten (10) director nominees named in the proxy statement.
2. Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2017.
3. Non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers.
4. on-binding, advisory vote regarding the frequency of the voting with respect to the compensation of the Company’s Named Executive Officers.
5. Consider and vote upon the stockholder proposal set forth in this proxy statement, if presented.
6. Consider any other business properly brought before the meeting.
|
| 2017-02-15 |
除权日：
美东时间 2017-03-29 每股派息0.40美元
|
| 2016-10-26 |
除权日：
美东时间 2017-01-10 每股派息0.29美元
|
| 2016-10-12 |
复牌提示：
2016-10-12 10:09:27 停牌，复牌日期 2016-10-12 10:29:30
|
| 2016-08-25 |
除权日：
美东时间 2016-10-11 每股派息0.29美元
|
| 2016-04-21 |
除权日：
美东时间 2016-06-28 每股派息0.29美元
|
| 2016-02-18 |
除权日：
美东时间 2016-03-29 每股派息0.29美元
|
| 2015-10-29 |
除权日：
美东时间 2015-12-28 每股派息0.29美元
|
| 2015-08-27 |
除权日：
美东时间 2015-09-28 每股派息0.29美元
|
| 2015-04-17 |
除权日：
美东时间 2015-06-26 每股派息0.29美元
|
| 2015-02-18 |
除权日：
美东时间 2015-03-27 每股派息0.28美元
|
| 2014-10-31 |
除权日：
美东时间 2014-12-29 每股派息0.28美元
|
| 2014-08-27 |
除权日：
美东时间 2014-09-26 每股派息0.28美元
|
| 2014-04-30 |
除权日：
美东时间 2014-06-26 每股派息0.28美元
|
| 2014-02-19 |
除权日：
美东时间 2014-03-27 每股派息0.27美元
|
| 2013-10-30 |
除权日：
美东时间 2013-12-27 每股派息0.27美元
|
| 2013-08-22 |
除权日：
美东时间 2013-09-26 每股派息0.27美元
|
| 2013-04-25 |
除权日：
美东时间 2013-06-26 每股派息0.27美元
|
| 2013-02-27 |
除权日：
美东时间 2013-03-26 每股派息0.26美元
|
| 2012-10-18 |
除权日：
美东时间 2012-12-27 每股派息0.26美元
|
| 2012-08-24 |
除权日：
美东时间 2012-09-26 每股派息0.26美元
|
| 2012-04-26 |
除权日：
美东时间 2012-06-27 每股派息0.26美元
|
| 2012-02-24 |
除权日：
美东时间 2012-03-28 每股派息0.25美元
|
| 2011-10-24 |
除权日：
美东时间 2011-12-28 每股派息0.25美元
|
| 2011-08-17 |
除权日：
美东时间 2011-09-28 每股派息0.25美元
|
| 2011-04-26 |
除权日：
美东时间 2011-06-28 每股派息0.25美元
|